Literature DB >> 2745207

Results of radiotherapy for inoperable locally advanced esophageal cancer.

T Okawa1, M Kita, M Tanaka, M Ikeda.   

Abstract

Three hundred and eleven patients with locally advanced esophageal cancer were treated by radiation therapy from 1968 to 1983 at Tokyo Women's Medical College. Of these, 288 patients with previously untreated, histologically confirmed squamous cell carcinoma but previously treated with curative intent, were eligible for analysis. The cumulative 5-year survival rate of 288 patients given radical radiotherapy was 9.0%. Sex, tumor length, and Stage (AJC) had a great influence on prognosis. The five-year survival rate in males was 5.4% and in females was 22.4%. The five-year survival rate in cases with a tumor length of 5 cm or less was 17.7% in 5-10 cm was 10.0%, and in 10 cm or above was 2.8% and they were 20.2% for Stage I, 9.9% for Stage II, and 2.6% for Stage III. There were no significant differences of survival rate among age, tumor site, and tumor type on X ray film. This data suggests that comparatively early, small-volume tumors share a significant potential for cure by radiotherapy, but potent combined therapy is necessary for the treatment of advanced cancers.

Entities:  

Mesh:

Year:  1989        PMID: 2745207     DOI: 10.1016/0360-3016(89)90369-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectives.

Authors:  Kohei Shitara; Kei Muro
Journal:  Gastrointest Cancer Res       Date:  2009-03

2.  Update: modern approaches to the treatment of localized esophageal cancer.

Authors:  James Welsh; Arya Amini; Anna Likhacheva; Jeremy Erasmus J; Daniel Gomez; Marta Davila; Reza J Mehran; Ritsuko Komaki; Zhongxing Liao; Wayne L Hofstetter; Jeffrey Lee H; Manoop S Bhutani; Jaffer A Ajani
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

3.  The effect of neoadjuvant chemoradiotherapy on airway colonization and postoperative respiratory complications in patients undergoing oesophagectomy for oesophageal cancer.

Authors:  Reza Bagheri; Mohammad Taghi RajabiMashhadi; Kiyarash Ghazvini; Amir Asnaashari; Ali Zahediyan; Mehdi Abasi Sahebi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-05

4.  Analysis of different fractionations of three-dimensional conformable radiotherapy for esophageal cancer.

Authors:  Zhiqian Ma; Yan Zhang; Xiaofang Chen; Chaoxing Liu; Huijun Xu; Peng Zhao
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length?

Authors:  Reubendra Jeganathan; James McGuigan; Frederick Campbell; Thomas Lynch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-16       Impact factor: 9.236

Review 6.  [Radiotherapy in the multimodal treatment of esophageal carcinoma. A review].

Authors:  P Fritz; M Wannenmacher
Journal:  Strahlenther Onkol       Date:  1997-06       Impact factor: 4.033

Review 7.  p53 gene therapy for esophageal cancer.

Authors:  Hideaki Shimada; Hisahiro Matsubara; Takenori Ochiai
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 8.  Gastroesophageal junction adenocarcinoma.

Authors:  S G Swisher; P W Pisters; R Komaki; S Lahoti; J A Ajani
Journal:  Curr Treat Options Oncol       Date:  2000-12

9.  Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experience.

Authors:  Robert Díaz; Gaspar Reynes; Alejandro Tormo; Manuel de Juan; Regina Gironés; Angel Segura; Jorge Aparicio; Paula Richart; Helena de la Cueva; José García
Journal:  Clin Transl Oncol       Date:  2009-12       Impact factor: 3.405

10.  Clinical characteristics and outcome of patients with stage III esophageal carcinoma: a single-center experience from Turkey.

Authors:  Vahide I Ugur; Sakire P Kara; Bulent Kucukplakci; Taciser Demirkasimoglu; Cem Misirlioglu; Aytul Ozgen; Yesim Elgin; Ergun Sanri; Kadri Altundag; Nadi Ozdamar
Journal:  Med Oncol       Date:  2007-07-20       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.